Synthesis and antimicrobial activity of 4-amino trinems

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 14, 1996, Pages 1683-1688

  Tranquillini, Maria Elvira ^a   Araldi, Gian Luca ^a   Donati, Daniele ^a   Pentassuglia, Giorgio ^a   Pezzoli, Anna ^a   Ursini, Antonella ^a  

^a GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SANFETRINEM; TRINEM DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; REACTION ANALYSIS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0030598678     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00292-2     Document Type: Article

References (18)

1. 1. a) Tamburini, B.; Perboni, A.; Rossi, T.; Donati, D.; Andreotti, D.; Gaviraghi, G.; Carlesso, R.; Bismara, C. Eur. Patent Applic. 1991, EP 0416 953 A2; Chem. Abstr. 116, 235337t, 1992.
2. b) Perboni, A.; Tamburini, B.; Rossi, T.; Donati, D.; Tarzia, G.; Gaviraghi, G. in Recent Advances in the Chemistry of Anti-infective Agents; Bentley, P.H.; Ponsford, R. Eds., The Royal Society of Chemistry, T. Graham House: Cambridge, 1992, pp.21-35.
3. 2. For more recent publications see: a) Di Fabio, R.; Feriani, A; Gaviraghi, G.; Rossi, T. Bioorg. Med. Chem. Lett. 1995, 5, 1235.
4. b) Hanessian, S.; Rozema, M.J.; Reddy, G.B.; Braganza, J.F. Bioorg. Med. Chem. Lett. 1995, 5, 2535.
5. c) Rossi, T.; Biondi, S.; Contini, S.; Thomas, R.J.; Marchioro, C. J. Am. Chem. Soc. 1995, 117, 9604.
6. d) Bismara, C.; Di Fabio, R.; Donati, D.; Rossi, T.; Thomas, R.J. Tetrahedron Lett. 1995, 36, 4283.
7. e) Padova, A.; Roberts, S.M.; Donati, D.; Marchioro, C.; Perboni, A. Tetrahedron 1996, 52, 263.
8. f) Andreotti, D.; Rossi, T.; Gaviraghi, G.; Donati, D.; Marchioro, C.; Di Modugno, E.; Perboni, A. Bioorg. Med. Chem. Lett. 1996, 6, 491.
9. g) Biondi, S.; Gaviraghi, G.; Rossi, T. Bioorg. Med. Chem. Lett. 1996, 6, 525.
10. 3. Di Modugno, E.; Erbetti, I.; Ferrari, L.; Galassi, G; Hammond, S.M., Xerri, L. Antimicrob. Agents Chemother. 1994, 38, 2362.
11. 4. Perboni, A.; Bismara, C.; Pentassuglia, G. Eur. Patent Applic. 1992, EP 0466 509 A1.
12. 5. Epoxide opening with ammonia was attempted, but without success.
13. 6. Whitten, J.P.; McCarthy, J.R.; Whalon, M.R. J. Org. Chem. 1985, 50, 4399.
14. 7. Piancatelli, G.; Scettri, A.; D' Auria, M. Synthesis 1982, 245.
15. 8. Mancuso, A.J.; Swern, D.; Synthesis 1981, 165.
16. 9. Yoshida, A.; Tajima, Y.; Takeda, N.; Oida, S. Tetrahedron Lett. 1984, 25, 2793.
17. 10. Jeffrey, P.D.; Mc Combie, S.W. J. Org. Chem. 1982, 47, 587.
18. 5 CFU/ml S. a. 663= Staphylococcus aureus 663E ; S. a. 853= Staphylococcus aureus 853E β-Lactamases producing strains, E. faecalis 850 = Enterobacter faecalis 850 ; E. coli 1850= Escherichia coli 1850E; E. coli 1919 = Escherichia coli 1919E β-Lactamases producing strains; P. aeruginosa 1911 = Pseudomonas aeruginosa 1911E.